These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25243)

  • 1. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes.
    Guckian JC; Christensen WD; Fine DP
    J Immunol; 1978 May; 120(5):1580-6. PubMed ID: 659863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the alternate complement pathway in opsonization of several bacterial species.
    Forsgren A; Quie PG
    Infect Immun; 1974 Aug; 10(2):402-4. PubMed ID: 4152919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    Infect Immun; 1981 Sep; 33(3):714-24. PubMed ID: 7026443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
    Schweinle JE
    Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
    Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J
    Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of serum concentration on opsonization by the classical and alternative complement pathways.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1980 Feb; 27(2):693-6. PubMed ID: 6991425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.